Use App
Trending
News
Earnings
All
DIA
0.48%
SPY
0.10%
QQQ
1.12%
Trending
SPCX
2.68%
ALGO
3.52%
SPCH
5.67%
INTC
7.89%
FRMI
17.09%
UCO
0.66%
WOLF
11.05%
CHTR
2.52%
APP
1.73%
BE
14.91%
SPCX
2.68%
ALGO
3.52%
SPCH
5.67%
INTC
7.89%
FRMI
17.09%
UCO
0.66%
WOLF
11.05%
CHTR
2.52%
APP
1.73%
BE
14.91%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
ALNY
Exchange:
NASDAQ
·
Updated 07:34 PM EDT
ALNY
Alnylam Pharmaceuticals Inc
$271.40
$3.03
(1.13%)
Today
·
Closed $271.77
$0.37
(0.14%)
After Hours
4
,
5
0
5
4
,
5
0
5
Earnings
Jul 30
Mkt Cap
$35.88B
Vol
1.15M
Full Chart
Fundamentals
Mkt Cap
$35.88B
Volume
-
52W High
$495.55
52W Low
$262.21
PE Ratio
64.57
Avg. Volume
1.27M
EPS (Annual)
$2.33
P/B
33.72
Rev/Employee
$1,485,574.80
Earnings
Jul 30
Advertisement
|
Remove ads.
Latest ALNY News
View
Alnylam Pharmaceuticals (ALNY) Reports Next Week: Wall Street Expects Earnings Growth
Zacks
Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results
Business Wire
Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease
Business Wire
Loading...
Top Discussions
HIMS
$HIMS stock is tumbling today, reversing yesterday's rally, even after an FDA panel recommended adding several peptides to the compounding list. Are you buying the dip?
5
6
941 votes
SPY
What do you think the S&P 500's ($SPY) return will be next week?
32
61
9K votes
HIMS
The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for $HIMS. How do you think it goes?
5
2
524 votes
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile